Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Pharmacologically active compounds in the environment and their chirality

Identifieur interne : 001637 ( Main/Exploration ); précédent : 001636; suivant : 001638

Pharmacologically active compounds in the environment and their chirality

Auteurs : Barbara Kasprzyk-Hordern [Royaume-Uni]

Source :

RBID : ISTEX:D3DFA18ACF99F301F2B1EB008AF224CA47EDE76D

English descriptors

Abstract

Pharmacologically active compounds including both legally used pharmaceuticals and illicit drugs are potent environmental contaminants. Extensive research has been undertaken over the recent years to understand their environmental fate and toxicity. The one very important phenomenon that has been overlooked by environmental researchers studying the fate of pharmacologically active compounds in the environment is their chirality. Chiral drugs can exist in the form of enantiomers, which have similar physicochemical properties but differ in their biological properties such as distribution, metabolism and excretion, as these processes (due to stereospecific interactions of enantiomers with biological systems) usually favour one enantiomer over the other. Additionally, due to different pharmacological activity, enantiomers of chiral drugs can differ in toxicity. Furthermore, degradation of chiral drugs during wastewater treatment and in the environment can be stereoselective and can lead to chiral products of varied toxicity. The distribution of different enantiomers of the same chiral drug in the aquatic environment and biota can also be stereoselective. Biological processes can lead to stereoselective enrichment or depletion of the enantiomeric composition of chiral drugs. As a result the very same drug might reveal different activity and toxicity and this will depend on its origin and exposure to several factors governing its fate in the environment. In this critical review a discussion of the importance of chirality of pharmacologically active compounds in the environmental context is undertaken and suggestions for directions in further research are made. Several groups of chiral drugs of major environmental relevance are discussed and their pharmacological action and disposition in the body is also outlined as it is a key factor in developing a full understanding of their environmental occurrence, fate and toxicity. This review will be of interest to environmental scientists, especially those interested in issues associated with environmental contamination with pharmacologically active compounds and chiral pollutants. As the review will outline current state of knowledge on chiral drugs, it will be of value to anyone interested in the phenomenon of chirality, chiral drugs, their stereoselective disposition in the body and environmental fate (212 references).

Url:
DOI: 10.1039/c000408c


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Pharmacologically active compounds in the environment and their chirality</title>
<author wicri:is="90%">
<name sortKey="Kasprzyk Hordern, Barbara" sort="Kasprzyk Hordern, Barbara" uniqKey="Kasprzyk Hordern B" first="Barbara" last="Kasprzyk-Hordern">Barbara Kasprzyk-Hordern</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D3DFA18ACF99F301F2B1EB008AF224CA47EDE76D</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1039/c000408c</idno>
<idno type="url">https://api.istex.fr/ark:/67375/QHD-SB3TSB0M-N/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001E40</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001E40</idno>
<idno type="wicri:Area/Istex/Curation">001E40</idno>
<idno type="wicri:Area/Istex/Checkpoint">000582</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000582</idno>
<idno type="wicri:doubleKey">0306-0012:2010:Kasprzyk Hordern B:pharmacologically:active:compounds</idno>
<idno type="wicri:Area/Main/Merge">001640</idno>
<idno type="wicri:Area/Main/Curation">001637</idno>
<idno type="wicri:Area/Main/Exploration">001637</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Pharmacologically active compounds in the environment and their chirality</title>
<author wicri:is="90%">
<name sortKey="Kasprzyk Hordern, Barbara" sort="Kasprzyk Hordern, Barbara" uniqKey="Kasprzyk Hordern B" first="Barbara" last="Kasprzyk-Hordern">Barbara Kasprzyk-Hordern</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Huddersfield, Department of Chemical and Biological Sciences, School of Applied Sciences, Queensgate, Huddersfield HD1 3DH</wicri:regionArea>
<wicri:noRegion>Huddersfield HD1 3DH</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Bath, Department of Chemistry, Faculty of Science, Bath BA2 7AY</wicri:regionArea>
<wicri:noRegion>Bath BA2 7AY</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Royaume-Uni</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Chemical Society Reviews</title>
<title level="j" type="abbrev">Chem. Soc. Rev.</title>
<idno type="ISSN">0306-0012</idno>
<idno type="eISSN">1460-4744</idno>
<imprint>
<publisher>The Royal Society of Chemistry.</publisher>
<date type="published" when="2010">2010</date>
<biblScope unit="volume">39</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="4466">4466</biblScope>
<biblScope unit="page" to="4503">4503</biblScope>
</imprint>
<idno type="ISSN">0306-0012</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0306-0012</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Achiral</term>
<term>Active enantiomer</term>
<term>Acute toxicity</term>
<term>Amphetamine</term>
<term>Anaesthetic</term>
<term>Anal</term>
<term>Analgesic</term>
<term>Antiarrhythmic</term>
<term>Antidepressant</term>
<term>Antiepileptic</term>
<term>Antipsychotic</term>
<term>Aquatic</term>
<term>Aquatic environment</term>
<term>Aquatic organisms</term>
<term>Atenolol</term>
<term>Barcelo</term>
<term>Benzodiazepine</term>
<term>Bioactive</term>
<term>Blocker</term>
<term>Brocks</term>
<term>Castiglioni</term>
<term>Centre</term>
<term>Characterised</term>
<term>Chem</term>
<term>Chemosphere</term>
<term>Chiral</term>
<term>Chiral centre</term>
<term>Chiral centres</term>
<term>Chiral drug</term>
<term>Chiral drugs</term>
<term>Chiral inversion</term>
<term>Chiral metabolites</term>
<term>Chiral nsaids</term>
<term>Chirality</term>
<term>Chromatogr</term>
<term>Citalopram</term>
<term>Clin</term>
<term>Codeine</term>
<term>Contaminant</term>
<term>Daphnid</term>
<term>Diazepam</term>
<term>Ecotoxicity</term>
<term>Enantiomer</term>
<term>Enantiomeric</term>
<term>Enantiomeric composition</term>
<term>Enantioselective</term>
<term>Enantioselectivity</term>
<term>Environ</term>
<term>Environmental fate</term>
<term>Environmental matrices</term>
<term>Environmental occurrence</term>
<term>Fanelli</term>
<term>Fluoxetine</term>
<term>Glucuronic</term>
<term>Glucuronidation</term>
<term>Glucuronide</term>
<term>Greifenesee</term>
<term>High concentrations</term>
<term>Ibuprofen</term>
<term>Illicit drugs</term>
<term>Isomer</term>
<term>Ketoprofen</term>
<term>Labetalol</term>
<term>Magna</term>
<term>Matrix</term>
<term>Mdma</term>
<term>Mehvar</term>
<term>Metabolised</term>
<term>Metabolism</term>
<term>Metabolite</term>
<term>Methamphetamine</term>
<term>Metoprolol</term>
<term>Mirtazapine</term>
<term>Naproxen</term>
<term>Nsaid</term>
<term>Omeprazole</term>
<term>Other hand</term>
<term>Oxazepam</term>
<term>Paroxetine</term>
<term>Pathway</term>
<term>Pentobarbital</term>
<term>Pharmaceutical</term>
<term>Pharmacodynamics</term>
<term>Pharmacokinetic</term>
<term>Pharmacokinetics</term>
<term>Pharmacol</term>
<term>Pharmacological activity</term>
<term>Pharmacologically</term>
<term>Phenytoin</term>
<term>Pollutant</term>
<term>Promelas</term>
<term>Propafenone</term>
<term>Propranolol</term>
<term>Racemate</term>
<term>Racemates</term>
<term>Racemic</term>
<term>Racemic form</term>
<term>Racemic mixture</term>
<term>Receptor</term>
<term>Reddy</term>
<term>Royal society</term>
<term>Salbutamol</term>
<term>Same drug</term>
<term>Serotonin</term>
<term>Sertraline</term>
<term>Single enantiomer</term>
<term>Sotalol</term>
<term>Ssri</term>
<term>Stereoisomers</term>
<term>Stereoselective</term>
<term>Stereoselective metabolism</term>
<term>Stereoselectivity</term>
<term>Surface water</term>
<term>Surface waters</term>
<term>Technol</term>
<term>Temazepam</term>
<term>Ternes</term>
<term>Thioridazine</term>
<term>Tonne</term>
<term>Total environ</term>
<term>Toxicity</term>
<term>Toxicol</term>
<term>Tramadol</term>
<term>Trimipramine</term>
<term>Uoxetine</term>
<term>Venlafaxine</term>
<term>Verapamil</term>
<term>Warfarin</term>
<term>Wastewater</term>
<term>Wastewater treatment</term>
<term>Wwtp</term>
<term>Wwtp1</term>
<term>Wwtp2</term>
<term>Wwtps</term>
<term>Zuccato</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Pharmacologically active compounds including both legally used pharmaceuticals and illicit drugs are potent environmental contaminants. Extensive research has been undertaken over the recent years to understand their environmental fate and toxicity. The one very important phenomenon that has been overlooked by environmental researchers studying the fate of pharmacologically active compounds in the environment is their chirality. Chiral drugs can exist in the form of enantiomers, which have similar physicochemical properties but differ in their biological properties such as distribution, metabolism and excretion, as these processes (due to stereospecific interactions of enantiomers with biological systems) usually favour one enantiomer over the other. Additionally, due to different pharmacological activity, enantiomers of chiral drugs can differ in toxicity. Furthermore, degradation of chiral drugs during wastewater treatment and in the environment can be stereoselective and can lead to chiral products of varied toxicity. The distribution of different enantiomers of the same chiral drug in the aquatic environment and biota can also be stereoselective. Biological processes can lead to stereoselective enrichment or depletion of the enantiomeric composition of chiral drugs. As a result the very same drug might reveal different activity and toxicity and this will depend on its origin and exposure to several factors governing its fate in the environment. In this critical review a discussion of the importance of chirality of pharmacologically active compounds in the environmental context is undertaken and suggestions for directions in further research are made. Several groups of chiral drugs of major environmental relevance are discussed and their pharmacological action and disposition in the body is also outlined as it is a key factor in developing a full understanding of their environmental occurrence, fate and toxicity. This review will be of interest to environmental scientists, especially those interested in issues associated with environmental contamination with pharmacologically active compounds and chiral pollutants. As the review will outline current state of knowledge on chiral drugs, it will be of value to anyone interested in the phenomenon of chirality, chiral drugs, their stereoselective disposition in the body and environmental fate (212 references).</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Kasprzyk Hordern, Barbara" sort="Kasprzyk Hordern, Barbara" uniqKey="Kasprzyk Hordern B" first="Barbara" last="Kasprzyk-Hordern">Barbara Kasprzyk-Hordern</name>
</noRegion>
<name sortKey="Kasprzyk Hordern, Barbara" sort="Kasprzyk Hordern, Barbara" uniqKey="Kasprzyk Hordern B" first="Barbara" last="Kasprzyk-Hordern">Barbara Kasprzyk-Hordern</name>
<name sortKey="Kasprzyk Hordern, Barbara" sort="Kasprzyk Hordern, Barbara" uniqKey="Kasprzyk Hordern B" first="Barbara" last="Kasprzyk-Hordern">Barbara Kasprzyk-Hordern</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001637 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001637 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D3DFA18ACF99F301F2B1EB008AF224CA47EDE76D
   |texte=   Pharmacologically active compounds in the environment and their chirality
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021